[18F]FSPG

DRUG2 trials

Sponsors

Asan Foundation, Asan Medical Center

Conditions

Crohn DiseaseGraft RejectionHeart TransplantationInflammatory Bowel DiseasesLiver TransplantationUlcerative Colitis

Phase 2

Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease

CompletedNCT03546868

Asan FoundationCrohn Disease, Inflammatory Bowel Diseases, Ulcerative Colitis

Start: 2018-08-14End: 2019-01-11Updated: 2020-12-14

Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

CompletedNCT04488094

Asan Medical CenterGraft Rejection, Heart Transplantation, Liver Transplantation

Start: 2020-11-18End: 2023-03-31Updated: 2023-07-20

Related Papers

PET Imaging of System x<sub>C</sub><sup>−</sup> in Immune Cells for Assessment of Disease Activity in Mice and Patients with Inflammatory Bowel Disease

Journal of Nuclear Medicine2022-01-279 citations